...
首页> 外文期刊>Current Issues in Pharmacy and Medical Sciences >Modern kinetic spectrophotometric procedure for estimation of furosemide drug as bulk form and in pharmaceuticals preparations
【24h】

Modern kinetic spectrophotometric procedure for estimation of furosemide drug as bulk form and in pharmaceuticals preparations

机译:现代动力学分光光度法估算速尿药物的散装形式和药物制剂

获取原文
           

摘要

A simple, rapid, sensitive, inexpensive and easy to perform kinetic spectrophotometric procedure for the investigation of trace quantities of the drug, furosemide (FRO), as bulk and in the pharmaceutical preparations, has been improved upon. The enhanced method was depended on the fashioning of the Schiff ‘s base by the reaction of the aldehyde group present in the 5-sulfo salicylaldehyde reagent, and the primary amino group present in furosemide. The latter acts as a ligand for the formation of an intense colored complex with Co(II) in an acidic medium, with maximum absorption at 608 nm. In the work, kinetic spectrophotometrics were established through the fixed time method. Moreover, Beer’s law was applied on the range of concentration between 5-100 ppm, while the molar absorptivity and the Sandell sensitivity were 3.9295×104 l.mol~(?1)cm~(?1), 0.008 μg.cm~(?2), respectively. The detection limit (LOD) was 2.133 μg/ml~(?1), and LOQ was 1.105 μg/ml~(?1). Ideal circumstances for all colour improvement were seen, and the suggested procedure has been effectively employed in investigating amounts of furosemide (FRO) in bulk forms and in pharmaceutical preparations (tablets, injection sample). Additives and general excipient materials did not affect the studied method. A statistical comparison between the results that were obtained from the reference method gave good agreement.
机译:改进了一种简单,快速,灵敏,便宜且易于执行的动力学分光光度法,用于研究痕量的散装和药物制剂中的速尿(FRO)。增强方法取决于通过5-磺基水杨醛试剂中存在的醛基和速尿中存在的伯氨基的反应形成席夫碱。后者充当配体,可在酸性介质中与Co(II)形成强烈的有色络合物,并在608 nm处具有最大吸收。在工作中,通过固定时间方法建立了动力学分光光度法。此外,比尔定律适用于5-100 ppm的浓度范围,摩尔吸收率和Sandell灵敏度分别为3.9295×104 l.mol〜(?1)cm〜(?1),0.008μg.cm〜( 2)。检测限(LOD)为2.133μg/ ml·(Δ1),LOQ为1.105μg/ ml·(Δ1)。可以看到所有颜色均得到改善的理想情况,并且所建议的程序已有效地用于调查散装形式和药物制剂(片剂,注射剂样品)中速尿(FRO)的量。添加剂和一般赋形剂材料不会影响所研究的方法。从参考方法获得的结果之间的统计比较给出了很好的一致性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号